Stockreport

Veracyte Announces New Data at AUA 2026 Highlighting the Power of the Decipher Portfolio to Advance Personalized Care in Urologic Cancers

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF Studies demonstrate clinical utility of Decipher Bladder molecular subtyping in bladder cancer and the expanding impact of Decipher Prostate in studies using real-world [Read more]